ANGELA WELCH: Open Payments
NPI 1699243592 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 54 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $970 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $526 |
| Janssen Biotech, Inc. | 14 | $188 |
| Madrigal Pharmaceuticals | 2 | $144 |
| QOL Medical, LLC | 4 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $85 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Braintree Laboratories, Inc. | 2 | $33 |
| Lilly USA, LLC | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: RINVOQ, SKYRIZI, TREMFYA, REZDIFFRA, Sucraid, ENTYVIO, LINZESS, CREON.
Industry payments across OH — which companies pay providers there.
